Abstract

The autonomic nervous system (ANS) has a significant influence on the structural integrity and electrical conductivity of the atria. Aberrant activation of the sympathetic nervous system can induce heterogeneous changes with arrhythmogenic potential which can result in atrial tachycardia, atrial tachyarrhythmias and atrial fibrillation (AF). Methods to modulate autonomic activity primarily through reduction of sympathetic outflow reduce the incidence of spontaneous or induced atrial arrhythmias in animal models and humans, suggestive of the potential application of such strategies in the management of AF. In this review we focus on the relationship between the ANS, sympathetic overdrive and the pathophysiology of AF, and the potential of sympathetic neuromodulation in the management of AF. We conclude that sympathetic activity plays an important role in the initiation and maintenance of AF, and modulating ANS function is an important therapeutic approach to improve the management of AF in selected categories of patients. Potential therapeutic applications include pharmacological inhibition with central and peripheral sympatholytic agents and various device based approaches. While the role of the sympathetic nervous system has long been recognized, new developments in science and technology in this field promise exciting prospects for the future.

Highlights

  • Frontiers in NeuroscienceSympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation

  • The autonomic nervous system (ANS) has a significant influence on the structural integrity and electrical conductivity of the atria

  • In this review we focus on the relationship between the ANS, sympathetic overdrive and the pathophysiology of atrial fibrillation (AF), and the potential of sympathetic neuromodulation in the management of AF

Read more

Summary

Frontiers in Neuroscience

Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation. Methods to modulate autonomic activity primarily through reduction of sympathetic outflow reduce the incidence of spontaneous or induced atrial arrhythmias in animal models and humans, suggestive of the potential application of such strategies in the management of AF. The heart is extensively innervated and effectively regulated by the autonomic nervous system (ANS) through its sympathetic and parasympathetic branches (Kimura et al, 2012). GP are clusters of ganglia from different subplexi and function as an intersection point of parasympathetic and sympathetic nerves and interconnect the intrinsic ANS (Armour et al, 1997; Hou et al, 2007; MalcolmeLawes et al, 2013). The instability theory of Ca2+-handling has been recently challenged (Christ et al, 2014; Greiser et al, 2014), raising the hypothesis that Ca2+-induced calcium release may mediate AF in structurally remodeled atria, demonstrating how a modified autonomic tone can cause AF (Nguyen et al, 2009)

Focal Initiation and Maintenance of AF
PATHOPHYSIOLOGY OF ATRIAL FIBRILLATION
The Multiple Wavelet Hypothesis and Rotors as Sources of AF
CLINICAL CONDITIONS THAT MAY ACT AS PREDISPOSING FACTORS TO AF
Association with AF
Pharmacological Sympathetic Inhibition
RENAL DENERVATION AND GANGLIONATED PLEXI ABLATION
PV ISOLATION
BOTULINUM TOXIN INJECTION
STELLATE GANGLION BLOCKADE
HIGH THORACIC EPIDURAL ANESTHESIA
CAROTID BODY ABLATION
Findings
CONCLUSION AND PERSPECTIVES
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.